Impact of covid-19 in achr myasthenia gravis and the safety of vaccines: data from an italian cohort

HIGHLIGHTS

SUMMARY

    The broader use of anesthetics, intubation, and mechanical ventilation in COVID-19 patients hospitalized in Intensive Care Units might have led to additional risks for patients with generalized MG. Immunosuppressant drugs usually protect from MG exacerbation and worse COVID-19 outcomes in MG patients. This topic has already been discussed in some editorials supporting COVID-19 vaccination in NMD patients, but there is again a lack of data from MG patients. There is widespread concern for the safety of SARS-CoV-2 vaccines in patients affected by autoimmune diseases such as MG. The MG . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?